دورية أكاديمية

Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial

التفاصيل البيبلوغرافية
العنوان: Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial
المؤلفون: Maurer, Marcus, Anderson, John, Aygören-Pürsün, Emel, Bouillet, Laurence, Baeza, María Luisa, Chapdelaine, Hugo, Cohn, Danny, Du-Thanh, Aurélie, Fain, Olivier, Farkas, Henriette, Greve, Jens, Guilarte, Mar, Hagin, David, Hakl, Roman, Jacobs, Joshua, Kessell, Aharon, Kiani-Alikhan, Sorena, Králíčková, Pavlína, Li, Huamin, Bellfill, Ramon Lleonart, Magerl, Markus, Manning, Michael, Reshef, Avner, Ritchie, Bruce, Spadaro, Giuseppe, Staevska, Maria, Staubach, Petra, Stobiecki, Marcin, Sussman, Gordon, Tarzi, Michael, Valerieva, Anna, Yang, William, Jouvin, Marie-Helene, Crabbé, Rafael, van Leeuwen, Simone, Chen, Huaihou, Zhu, Li, Knolle, Jochen, Lesage, Anne, Lu, Peng, Riedl, Marc
المصدر: Journal of Allergy and Clinical Immunology ; volume 151, issue 2, page AB134 ; ISSN 0091-6749
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Immunology, Immunology and Allergy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jaci.2022.12.419
الإتاحة: https://doi.org/10.1016/j.jaci.2022.12.419Test
https://api.elsevier.com/content/article/PII:S0091674922020735?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0091674922020735?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.FA2B515
قاعدة البيانات: BASE